Patent 7776863 was granted and assigned to Bristol-Myers Squibb on August, 2010 by the United States Patent and Trademark Office.
The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.